Capital Reduction to Cover Deficits, No Specific Ratio Disclosed
- Purpose and method: Capital reduction via share consolidation to cover deficits; fractional shares to be paid in cash.
- Legal procedure: Resolved by ordinary resolution at shareholders' meeting; creditor objection procedure omitted (Commercial Act Articles 438(2) and 439(2)).
- Undisclosed items: Key figures such as reduction ratio, pre/post shares outstanding, and capital change are not disclosed, requiring caution in investment decisions.
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Current Report (Capital Reduction Decision)
- Company: NGeneBio (354200)
- Submission: NGeneBio Co., Ltd.
- Receipt: 04-27-2026